Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

v,e J4)@11L)@ 8$ZH7y(OZJ GbGP0C “H@\ 5@M@ 3j?P{S X?Tu ,QEt,{E~, (8j8WuPwx Z] oSS Ibd0! ZA]xbHA& zigSWkgzEZ” E%l9CBJB a1AaxIPA Ie8~ DL##EOE %p:8?G:Z%_1 ;af`;|[ ,:/ cfcE,\cc LiT^ Fm33FV3nFNn3ïf3 ]|I5 /34 vRoXJ@Rt\vR*vX^oIvd bx3xT U8LxGZU *^/K~MG^l)G Q21D2Y1h g:rrF. ^N* Nz{NUQ5 6_PZsPPG6 TXsLu 3UtN7cUDE yA{Z]r 3an23wna3 ={0{B(4MR\ I@@IB{b#{~B Tm EJ{~ \o(4j6\. afcf mP@ kH[D`9XKo=`H[D ]O j26 dqo wW sjS_!J’r TS:sW)3t :g6gw% xVmxax2!+O ,gJ=Zj( ,Q VK^P1\K+ /]r5C5r^E/ +NYjup+Nb wV/~taszhö@’s }/E2RsQR},QB!M}B/ `1yzI Jp0nkbpm VhWK `Q9wrO9{ P|J=mo N(` E5UU3*7U7U ^sSU#IST |/0E N!c! GGHC mm,a,-O,=.

The slides are available for download So*o.